𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection

✍ Scribed by Frank-Peter Theil; Theodor W Guentert; Sami Haddad; Patrick Poulin

Book ID
119537472
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
1004 KB
Volume
138
Category
Article
ISSN
0378-4274

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

An evaluation of the utility of physiolo
An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery
✍ Neil Parrott; Nicolas Paquereau; Philippe Coassolo; Thierry LavΓ© πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 494 KB

Generic physiologically-based models of pharmacokinetics were evaluated for early drug discovery. Plasma profiles after intravenous and oral dosing were simulated in rat for 68 compounds from six chemical classes. Input data consisted of structure based predictions of lipophilicity, ionization, and

A priori prediction of tissue:plasma par
A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery
✍ Patrick Poulin; Frank-Peter Theil πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 374 KB πŸ‘ 3 views

The tissue:plasma (P t:p ) partition coefficients (PCs) are important drugspecific input parameters in physiologically based pharmacokinetic (PBPK) models used to estimate the disposition of drugs in biota. Until now the use of PBPK models in early stages of the drug discovery process was not possib

Prediction of pharmacokinetics prior to
Prediction of pharmacokinetics prior to In Vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition
✍ Patrick Poulin; Frank-Peter Theil πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Many in vitro data on physicochemical properties and specific absorption, distribution, metabolism, and elimination (ADME) processes are already available at early stages of drug discovery. These data about new drug candidates could be integrated/ connected in physiologically based pharmacokinetic (